AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Combining the Best People, Science and Technology Drives Clinical Trial Innovation
The film, which features scientific and medical experts from Fortrea, highlights how the company is driving innovation in clinical research to improve quality, accessibility and productivity to help get treatments to patients faster.
Clinical research is the engine of innovative modern medicine, paving the way for groundbreaking treatments such as immunotherapy for cancer care, mechanism-based approaches to neurodegenerative diseases, and antiretroviral therapies that make HIV a manageable chronic condition rather than a life-threatening disease.
However, the nuts and bolts of clinical trials are rooted in quite traditional methods and processes. Fortrea aims to modernize the way clinical trials are run with innovation that combines the best people, science and technology.
“Fortrea keeps patients at the heart of our work, frankly because most of us come to this industry with a passion for patients based on something we personally experienced,” said Fortrea Chairman and CEO Tom Pike. “But we go beyond that here. We are challenging industry norms and driving innovations. We are working with our customers and industry partners to look at processes, technology and data to speed up and increase innovation associated with clinical research.”
Trial design is one area of focus for innovation. Designing based on assumptions rather than real world data input can create inefficiencies. However, precisely applying real world data, technology and advanced analytics can improve the efficiency and effectiveness of the trial, leading to better outcomes.
Additionally, Fortrea researchers are looking at potential markers of drug efficacy earlier in the research process. Even with relatively small numbers of volunteers, researchers can observe changes in biomarkers that may point to the probability that experimental treatments may have an impact on a particular disease.
Fortrea is leaning into AI to drive innovation as well.
“It’s clear that artificial intelligence will impact the clinical research industry,” Pike said. “The ability to search large and numerous data sets and accelerate the corresponding analysis can provide tangible benefits to how clinical trials are conducted and synthesized.”
Watch ‘Transforming Lives’ on Fortrea.com or Fortrea’s YouTube channel.
Watch the Campaign Live on Reuters here.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X.
Fortrea Contacts
Hima Inguva (Investors) – 877-495-0816, [email protected]
Jennifer Minx (Media) – 919-410-4195, [email protected]
Kate Dillon (Media) – 646-818-9115, [email protected]
Claudia Gahan
Acumen Media
+44 20 3553 3664
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
